Pancreatic cancer is an extremely challenging cancer to treat, in part due to symptoms often going undetected until the cancer is in its advanced stages. The American Cancer Society estimates that more than 57,000 people in the United States will be diagnosed with pancreatic cancer in 2020, and the disease will cause more than 47,000 deaths. The incidence of pancreatic cancer has been increasing between 2007 and 2016, the latest period for which data are available.
Fortunately, laboratory and clinical studies being conducted at the UNC Lineberger Comprehensive Cancer Center and across the country are focused on generating insights on the causes of the disease, creating novel treatments and improving outcomes.
Here is some information on pancreatic cancer research underway at UNC Lineberger, as well as recent honors and awards, and a pancreatic cancer survivor’s perspective on her cancer journey.
Pancreatic Cancer Research
Yeh, Lipner lead study in JCI Insight
Researchers use innovative ideas to help fight pancreatic cancer
Researchers find out what’s keeping cancer-killing T-cells away from pancreatic cancer tumors
Pancreatic cancer tumor classification could optimize treatment choices
Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
Researchers develop method for separating tissue types in tumor samples
Pancreatic cancer patient beats the odds to thrive after diagnosis
Honors and Awards
Bryant recognized as Forbeck Scholar
U.S. Army awards grant to Pylayeva-Gupta for study of immune system in pancreatic cancer
Der named AAAS Fellow
NCI awards $2.2M to Pylayeva-Gupta to investigate immune responses in pancreatic cancer